Phase-II study of BBR 2778, a new aza-anthracenedione, in patients with relapsed aggressive non-Hodgkin lymphomas.

被引：0
|
作者：
Borchmann, P
Morschhauser, F
Schnell, R
Harousseau, JL
Gisselbrecht, C
Rudolph, C
Wilhelm, M
Derigs, H
Kutz, K
Leynardier, D
Verdi, E
Camboni, G
Engert, A
机构：
[1] Univ Cologne, Innere Med Klin, Cologne, Germany
[2] Jop Huriez, Lille, France
[3] CHU Hotel Dieu, Serv Hematol, Nantes, France
[4] Hop St Louis, Serv Hematol, Paris, France
[5] Carl Diehm Klinikum Cottbus, Innere Med Klin, Cottbus, Germany
[6] Universitatsklin, Innere Med Klin, Wurzburg, Germany
[7] Hesper Ltd, Allschwil, Switzerland
[8] Novuspharma Spa, Monza, Italy
[9] Univ Mainz, Innere Med Klin, D-6500 Mainz, Germany
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1441
引用
收藏
页码：341A / 341A
页数：1
相关论文
共 50 条
  • [31] Liposomal vincristine: A phase II trial in relapsed or refractory non-Hodgkin's lymphomas (NHL).
    Sarris, AH
    Romaguera, SJ
    Hagemeister, F
    Rodriguez, MA
    McLaughlin, P
    Dang, N
    Tsimberidou, AM
    Medeiros, LJ
    Samuels, B
    Oholendt, M
    Pate, O
    Burge, C
    Cabanillas, F
    BLOOD, 1999, 94 (10) : 94A - 94A
  • [32] Irinotecan in relapsed or refractory non-Hodgkin's lymphomas - Indications of activity in a phase II trial
    Sarris, AH
    Phan, A
    Goy, A
    Romaguera, J
    Hagemeister, FB
    Rodriguez, MA
    McLaughlin, P
    Pro, B
    Medeiros, LJ
    Samuels, B
    Mesina, O
    Bleyer, AW
    Cabanillas, F
    ONCOLOGY-NEW YORK, 2002, 16 (08): : 27 - 31
  • [33] Pixantrone for the treatment of adult patients with relapsed or refractory aggressive non-Hodgkin B-cell lymphomas
    Volpetti, Stefano
    Zaja, Francesco
    Fanin, Renato
    ONCOTARGETS AND THERAPY, 2014, 7 : 865 - 872
  • [34] Oral clofarabine for relapsed/refractory non-Hodgkin lymphomas: results of a phase 1 study
    Abramson, Jeremy S.
    Takvorian, Ronald W.
    Fisher, David C.
    Feng, Yang
    Jacobsen, Eric D.
    Brown, Jennifer R.
    Barnes, Jeffrey A.
    Neuberg, Donna S.
    Hochberg, Ephraim P.
    LEUKEMIA & LYMPHOMA, 2013, 54 (09) : 1915 - 1920
  • [35] Phase II Study of Alisertib, a Selective Aurora A Kinase Inhibitor, in Relapsed and Refractory Aggressive B- and T-Cell Non-Hodgkin Lymphomas
    Friedberg, Jonathan W.
    Mahadevan, Daruka
    Cebula, Erin
    Persky, Daniel
    Lossos, Izidore
    Agarwal, Amit B.
    Jung, JungAh
    Burack, Richard
    Zhou, Xiaofei
    Leonard, E. Jane
    Fingert, Howard
    Danaee, Hadi
    Bernstein, Steven H.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (01) : 44 - U122
  • [36] Liposomal encapsulated doxorubicin (Caelyx) in the treatment of relapsed aggressive non-Hodgkin's lymphoma: A phase II study
    Macpherson, N.
    Belch, A.
    Taylor, M.
    Sutherland, J.
    Czaykowski, P.
    Connors, J.
    LEUKEMIA & LYMPHOMA, 2006, 47 (07) : 1327 - 1332
  • [37] PHASE-II STUDY OF AMSACRINE (M-AMSA) IN THE TREATMENT OF PATIENTS WITH NON-HODGKIN LYMPHOMA
    ABATE, G
    VILLARI, P
    COMELLA, P
    CASTELLO, G
    DAPRILE, M
    BRUNI, G
    PERGOLA, M
    ZARILLI, D
    HAEMATOLOGICA, 1984, 69 (04) : 501 - 501
  • [38] Outcome of treatment to the B-ALL protocol in patients with aggressive B-cell non-Hodgkin's lymphomas.
    Övermann, K
    Peest, D
    Ganser, A
    ANNALS OF ONCOLOGY, 2000, 11 : 107 - 107
  • [39] Head & neck aggressive non-Hodgkin lymphomas. Analysis of 189 patients treated by the GOELAMS 02&03 trials
    Desablens, B
    Gardembas, M
    LeMevel, A
    Abgrall, JF
    Gandhour, C
    LePrise, PY
    Tourani, JM
    Lagarde, N
    Colombat, P
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 1388 - 1388
  • [40] Multicenter phase II study of plitidepsin in patients with relapsed/refractory non-Hodgkin's lymphoma
    Ribrag, Vincent
    Caballero, Dolores
    Ferme, Christophe
    Zucca, Emanuele
    Arranz, Reyes
    Briones, Javier
    Gisselbrecht, Christian
    Salles, Gilles
    Gianni, Alessandro M.
    Gomez, Henry
    Kahatt, Carmen
    Corrado, Claudia
    Szyldergemajn, Sergio
    Extremera, Sonia
    de Miguel, Bernardo
    Cullell-Young, Martin
    Cavalli, Franco
    HAEMATOLOGICA, 2013, 98 (03) : 357 - 363
12345